Arrowpoint Asset Management »

Pliant Therapeutics shares owned by Arrowpoint Asset Management

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Arrowpoint Asset Management from 13F filings

Historical chart of Arrowpoint Asset Management investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Arrowpoint Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.1M 281k 18.11
2023-09-30 $4.9M 281k 17.34
2023-06-30 $5.1M 281k 18.12

More positions owned by Arrowpoint Asset Management

Alight Com Cl A (ALIT)
Rb Global (RBA)
J Global (ZD)
Trimble Navigation (TRMB)
Cargurus Com Cl A (CARG)
Euronet Worldwide (EEFT)
Matson (MATX)
Sensata Technologies Hldg Pl SHS (ST)
Quidel Corp (QDEL)
Steris Shs Usd (STE)
Acv Auctions Com Cl A (ACVA)
Merit Medical Systems (MMSI)
Churchill Downs (CHDN)
Okta Cl A (OKTA)
Kirby Corporation (KEX)

View all positions for Arrowpoint Asset Management

Top funds holding Pliant Therapeutics

T. Rowe Price Associates
First Light Asset Management
Laurion Capital Management
Vanguard Group
Blue Owl Capital Holdings
Redmile Group
Trv Gp Iv
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Franklin Resources
Casdin Capital
RA Capital Management
Deutsche Bank Aktiengesellschaft
Bessemer
Candriam Luxembourg S.C.A.

View all funds holding Pliant Therapeutics